Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Preclinical Development

NF-κB Is Required for Smac Mimetic-Mediated Sensitization of Glioblastoma Cells for γ-Irradiation–Induced Apoptosis

Rebecca Berger, Claudia Jennewein, Viola Marschall, Sabine Karl, Silvia Cristofanon, Liane Wagner, Sri HariKrishna Vellanki, Stephanie Hehlgans, Franz Rödel, Klaus-Michael Debatin, Albert C. Ludolph and Simone Fulda
Rebecca Berger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Jennewein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viola Marschall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabine Karl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvia Cristofanon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liane Wagner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sri HariKrishna Vellanki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Hehlgans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franz Rödel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus-Michael Debatin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert C. Ludolph
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Fulda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-11-0218 Published October 2011
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: August 2011 to January 2021

AbstractFull-text HTMLPDF
Total410127891852

Cited By

Article Information

Volume 10, Issue 10, pp. 1867-1875

DOI 
https://doi.org/10.1158/1535-7163.MCT-11-0218
PubMed 
21859841

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received March 24, 2011
  • Revision received August 9, 2011
  • Accepted August 15, 2011
  • Published first August 22, 2011.

Article Versions

  • Previous version (August 22, 2011 - 08:16).
  • Previous version (September 2, 2011 - 11:42).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2011 American Association for Cancer Research.

Author Information

  1. Rebecca Berger1,
  2. Claudia Jennewein2,
  3. Viola Marschall3,
  4. Sabine Karl2,
  5. Silvia Cristofanon3,
  6. Liane Wagner2,
  7. Sri HariKrishna Vellanki2,
  8. Stephanie Hehlgans4,
  9. Franz Rödel4,
  10. Klaus-Michael Debatin2,
  11. Albert C. Ludolph1, and
  12. Simone Fulda2,3
  1. Authors' Affiliations: 1Department of Neurology, University of Ulm, Ulm; 2University Children's Hospital, University of Ulm, Ulm; 3Institute for Experimental Cancer Research in Pediatrics; and 4Department of Radiation Therapy and Oncology, Goethe-University Frankfurt, Germany
  1. Corresponding Author:
    Simone Fulda, Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Komturstr. 3a, 60528 Frankfurt, Germany. Phone: 49-69-67866557; Fax: 49-69-6786659157; E-mail: simone.fulda{at}kgu.de
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 10 (10)
October 2011
Volume 10, Issue 10
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
NF-κB Is Required for Smac Mimetic-Mediated Sensitization of Glioblastoma Cells for γ-Irradiation–Induced Apoptosis
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
NF-κB Is Required for Smac Mimetic-Mediated Sensitization of Glioblastoma Cells for γ-Irradiation–Induced Apoptosis
Rebecca Berger, Claudia Jennewein, Viola Marschall, Sabine Karl, Silvia Cristofanon, Liane Wagner, Sri HariKrishna Vellanki, Stephanie Hehlgans, Franz Rödel, Klaus-Michael Debatin, Albert C. Ludolph and Simone Fulda
Mol Cancer Ther October 1 2011 (10) (10) 1867-1875; DOI: 10.1158/1535-7163.MCT-11-0218

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
NF-κB Is Required for Smac Mimetic-Mediated Sensitization of Glioblastoma Cells for γ-Irradiation–Induced Apoptosis
Rebecca Berger, Claudia Jennewein, Viola Marschall, Sabine Karl, Silvia Cristofanon, Liane Wagner, Sri HariKrishna Vellanki, Stephanie Hehlgans, Franz Rödel, Klaus-Michael Debatin, Albert C. Ludolph and Simone Fulda
Mol Cancer Ther October 1 2011 (10) (10) 1867-1875; DOI: 10.1158/1535-7163.MCT-11-0218
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • BiKEs and TriKEs Enhance NK Cell Effector Function
  • Ganetespib Activity in KRAS-Mutant NSCLCs
  • Aurora Kinase Targeting Triple-Negative Breast Cancer
Show more Preclinical Development
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement